Ponesimod: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ponesimod. Educational only — not medical advice.
Labeled uses
PONVORY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Source: FDA labeling via NIH DailyMed (set 5be69660…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.